SSI Strategy Case Study

Innovative gene therapy company obtained extraordinary clinical results, as such the pathway to launch of the product was accelerated.
Accelerated HEOR and RWE output required to ensure product could successfully achieve reimbursement
Company faced shifting market landscape and step-change in treatment with novel competition to its upcoming product launch
Value demonstration required to ensure a viable price and market opportunity – “likely to be most expensive drug in the world”
Data required to support market access was 2-3 years behind

Supported the value generation framework, focusing on creative ways to remediate gaps.
Built out and operated the HEOR and RWE function, in partnership with sole functional lead.
Created and operationalized an internal stakeholder management forum, which was required due to lack of understanding from internal team members.
Leveraged key trusted vendors to help perform the detailed analysis and modeling
Transitioned the strategy and supplemented internal hires to continue the rapid growth

In partnership with functional lead, SSI enabled the client to catch up to market access evidence generation needs
SSI supported the development of an international disease registry.
Avoided expensive head-to-head comparison with standard of care yet sufficient product differentiation
Developed staffing plans and assisted with onboarding. Defined requirements and geographical needs
Resulted in favorable pricing in the marketplace – demonstrating cost-effectiveness and justifying pricing

Accelerating Global HEOR & RWE Function Buildout & Support